Literature DB >> 16164763

Neuroimaging and the functional neuroanatomy of psychotherapy.

Joshua L Roffman1, Carl D Marci, Debra M Glick, Darin D Dougherty, Scott L Rauch.   

Abstract

BACKGROUND: Studies measuring the effects of psychotherapy on brain function are under-represented relative to analogous studies of medications, possibly reflecting historical biases. However, psychological constructs relevant to several modalities of psychotherapy have demonstrable neurobiological correlates, as indicated by functional neuroimaging studies in healthy subjects. This review examines initial attempts to measure directly the effects of psychotherapy on brain function in patients with depression or anxiety disorders.
METHOD: Fourteen published, peer-reviewed functional neuroimaging investigations of psychotherapy were identified through a MEDLINE search and critically reviewed. Studies were compared for consistency of findings both within specific diagnostic categories, and between specific modalities of psychotherapy. Results were also compared to predicted neural models of psychotherapeutic interventions.
RESULTS: Behavioral therapy for anxiety disorders was consistently associated with attenuation of brain-imaging abnormalities in regions linked to the pathophysiology of anxiety, and with activation in regions related to positive reappraisal of anxiogenic stimuli. In studies of major depressive disorder, cognitive behavioral therapy and interpersonal therapy were associated with markedly similar changes in cortical-subcortical circuitry, but in unexpected directions. For any given psychiatric disorder, there was only partial overlap between the brain-imaging changes associated with pharmacotherapy and those associated with psychotherapy.
CONCLUSIONS: Despite methodological limitations, initial neuroimaging studies have revealed convergent and mechanistically sensible effects of psychotherapy on brain function across a range of psychiatric disorders. Further research in this area may take advantage of emerging neuroimaging techniques to explore a broader range of psychotherapies, with the ultimate goal of improving clinical decision-making and treatment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16164763     DOI: 10.1017/S0033291705005064

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  40 in total

1.  Combined pharmacotherapy and psychotherapy for social anxiety disorder.

Authors:  Dan J Stein; Jonathan C Ipser
Journal:  Curr Psychiatry Rep       Date:  2010-08       Impact factor: 5.285

Review 2.  Neuroimaging of cognitive disability in schizophrenia: search for a pathophysiological mechanism.

Authors:  J D Ragland; J Yoon; M J Minzenberg; C S Carter
Journal:  Int Rev Psychiatry       Date:  2007-08

3.  The recognition and management of psychological reactions to stroke: a case discussion.

Authors:  Lyvia S Chriki; Szofia S Bullain; Theodore A Stern
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2006

4.  Functional neuroimaging: a brief overview and feasibility for use in chiropractic research.

Authors:  Reidar P Lystad; Henry Pollard
Journal:  J Can Chiropr Assoc       Date:  2009-03

Review 5.  When should psychotherapy be the treatment of choice for major depressive disorder?

Authors:  John C Markowitz
Journal:  Curr Psychiatry Rep       Date:  2008-12       Impact factor: 5.285

6.  Catehol-o-methyltransferase gene Val158met polymorphism as a potential predictor of response to computer-assisted delivery of cognitive-behavioral therapy among cocaine-dependent individuals: Preliminary findings from a randomized controlled trial.

Authors:  Kathleen M Carroll; Aryeh Herman; Elise E DeVito; Tami L Frankforter; Marc N Potenza; Mehmet Sofuoglu
Journal:  Am J Addict       Date:  2015-05-01

Review 7.  Neuroimaging for psychotherapy research: current trends.

Authors:  Carol P Weingarten; Timothy J Strauman
Journal:  Psychother Res       Date:  2014-02-17

8.  Quantitative morphology of the corpus callosum in obsessive-compulsive disorder.

Authors:  Katherine C Lopez; Francois Lalonde; Anand Mattai; Benjamin Wade; Liv Clasen; Judith Rapoport; Jay N Giedd
Journal:  Psychiatry Res       Date:  2013-03-01       Impact factor: 3.222

9.  Predictors of nonresponse to cognitive behavioural therapy or venlafaxine using glucose metabolism in major depressive disorder.

Authors:  Jakub Z Konarski; Sidney H Kennedy; Zindel V Segal; Mark A Lau; Peter J Bieling; Roger S McIntyre; Helen S Mayberg
Journal:  J Psychiatry Neurosci       Date:  2009-05       Impact factor: 6.186

10.  Brain imaging correlates of cognitive impairment in depression.

Authors:  Emma J Thomas; Rebecca Elliott
Journal:  Front Hum Neurosci       Date:  2009-10-09       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.